NCT04740918 2025-08-08
KATE3
Hoffmann-La Roche
Phase 3 Terminated
Clinical Trials
5 trialsNCT04732286 2025-05-08
A Study of Atezolizumab in Combination With Bevacizumab in Spanish Patients With Unresectable or Unsuitable for Locoregional Treatments Hepatocellular Carcinoma Not Previously Treated With Systemic Therapy
Hoffmann-La Roche
Phase 3 Terminated
NCT03024996 2023-08-03
IMmotion010
Hoffmann-La Roche
Phase 3 Terminated
NCT02450331 2023-06-18
IMvigor010
Hoffmann-La Roche
Phase 3 Terminated
NCT02409355 2019-02-15
A Study of Atezolizumab Compared With Gemcitabine Plus (+) Cisplatin or Carboplatin for PD-L1-Selected Participants With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower111)
Hoffmann-La Roche
Phase 3 Terminated